Orally administered live BCG and heat-inactivated Mycobacterium bovis protect bison against experimental bovine tuberculosis

Abstract Bovine tuberculosis (BTB) is an infectious disease of livestock and wildlife species that is caused by pathogenic members of the Mycobacterium tuberculosis complex such as Mycobacterium bovis. Due to the introduction of M. bovis-infected bison in the 1920s, BTB is now endemic in wood bison...

Full description

Saved in:
Bibliographic Details
Main Authors: Nirajan Niroula, Priya Ghodasara, Nelson Marreros, Bailey Fuller, Haley Sanderson, Slim Zriba, Stew Walker, Todd K. Shury, Jeffrey M. Chen
Format: Article
Language:English
Published: Nature Portfolio 2025-01-01
Series:Scientific Reports
Subjects:
Online Access:https://doi.org/10.1038/s41598-025-88176-0
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832571765629386752
author Nirajan Niroula
Priya Ghodasara
Nelson Marreros
Bailey Fuller
Haley Sanderson
Slim Zriba
Stew Walker
Todd K. Shury
Jeffrey M. Chen
author_facet Nirajan Niroula
Priya Ghodasara
Nelson Marreros
Bailey Fuller
Haley Sanderson
Slim Zriba
Stew Walker
Todd K. Shury
Jeffrey M. Chen
author_sort Nirajan Niroula
collection DOAJ
description Abstract Bovine tuberculosis (BTB) is an infectious disease of livestock and wildlife species that is caused by pathogenic members of the Mycobacterium tuberculosis complex such as Mycobacterium bovis. Due to the introduction of M. bovis-infected bison in the 1920s, BTB is now endemic in wood bison (Bison bison athabascae) population within the Wood Buffalo National Park (WBNP) in northern Canada. This disease poses a grave threat to the long-term survival of this ecologically and culturally important species and has the potential to cause zoonotic TB and spill over to BTB-free livestock and other bison herds that live in the surrounding areas. Thus, effective BTB control strategies in WBNP bison are urgently needed. To this end, we aerosol challenged young bison with different doses of virulent M. bovis and observed disease-associated delayed-type hypersensitivity, gross lung and lymph node pathology and histopathology, as well as M. bovis burden in target organs, thus confirming the establishment of BTB in challenged animals. We then assessed the safety and efficacy of oral live BCG versus oral heat-inactivated M. bovis (HIMB) given in a homologous prime-boost regimen in bison. While both BCG and HIMB offered protection against BTB, BCG-treated bison thrived more, presented with fewer lung lesions at necropsy and lower burden of virulent M. bovis than HIMB-treated animals. Strikingly, oral HIMB induced almost no delayed-type hypersensitivity to intradermal tuberculin while oral live BCG induced very low sensitivity to tuberculin in bison, indicating their potential as DIVA (differentiating infected from vaccinated animals) vaccines for use in this important wildlife species.
format Article
id doaj-art-f948a4fb68b843c0b3fae1bf42de6432
institution Kabale University
issn 2045-2322
language English
publishDate 2025-01-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj-art-f948a4fb68b843c0b3fae1bf42de64322025-02-02T12:23:16ZengNature PortfolioScientific Reports2045-23222025-01-0115111610.1038/s41598-025-88176-0Orally administered live BCG and heat-inactivated Mycobacterium bovis protect bison against experimental bovine tuberculosisNirajan Niroula0Priya Ghodasara1Nelson Marreros2Bailey Fuller3Haley Sanderson4Slim Zriba5Stew Walker6Todd K. Shury7Jeffrey M. Chen8Parks Canada Agency, Government of CanadaVaccine and Infectious Disease Organization (VIDO), University of SaskatchewanParks Canada Agency, Government of CanadaParks Canada Agency, Government of CanadaVaccine and Infectious Disease Organization (VIDO), University of SaskatchewanVaccine and Infectious Disease Organization (VIDO), University of SaskatchewanVaccine and Infectious Disease Organization (VIDO), University of SaskatchewanParks Canada Agency, Government of CanadaVaccine and Infectious Disease Organization (VIDO), University of SaskatchewanAbstract Bovine tuberculosis (BTB) is an infectious disease of livestock and wildlife species that is caused by pathogenic members of the Mycobacterium tuberculosis complex such as Mycobacterium bovis. Due to the introduction of M. bovis-infected bison in the 1920s, BTB is now endemic in wood bison (Bison bison athabascae) population within the Wood Buffalo National Park (WBNP) in northern Canada. This disease poses a grave threat to the long-term survival of this ecologically and culturally important species and has the potential to cause zoonotic TB and spill over to BTB-free livestock and other bison herds that live in the surrounding areas. Thus, effective BTB control strategies in WBNP bison are urgently needed. To this end, we aerosol challenged young bison with different doses of virulent M. bovis and observed disease-associated delayed-type hypersensitivity, gross lung and lymph node pathology and histopathology, as well as M. bovis burden in target organs, thus confirming the establishment of BTB in challenged animals. We then assessed the safety and efficacy of oral live BCG versus oral heat-inactivated M. bovis (HIMB) given in a homologous prime-boost regimen in bison. While both BCG and HIMB offered protection against BTB, BCG-treated bison thrived more, presented with fewer lung lesions at necropsy and lower burden of virulent M. bovis than HIMB-treated animals. Strikingly, oral HIMB induced almost no delayed-type hypersensitivity to intradermal tuberculin while oral live BCG induced very low sensitivity to tuberculin in bison, indicating their potential as DIVA (differentiating infected from vaccinated animals) vaccines for use in this important wildlife species.https://doi.org/10.1038/s41598-025-88176-0BisonBovine TBHeat Inactivated VaccineLive BCGDIVA
spellingShingle Nirajan Niroula
Priya Ghodasara
Nelson Marreros
Bailey Fuller
Haley Sanderson
Slim Zriba
Stew Walker
Todd K. Shury
Jeffrey M. Chen
Orally administered live BCG and heat-inactivated Mycobacterium bovis protect bison against experimental bovine tuberculosis
Scientific Reports
Bison
Bovine TB
Heat Inactivated Vaccine
Live BCG
DIVA
title Orally administered live BCG and heat-inactivated Mycobacterium bovis protect bison against experimental bovine tuberculosis
title_full Orally administered live BCG and heat-inactivated Mycobacterium bovis protect bison against experimental bovine tuberculosis
title_fullStr Orally administered live BCG and heat-inactivated Mycobacterium bovis protect bison against experimental bovine tuberculosis
title_full_unstemmed Orally administered live BCG and heat-inactivated Mycobacterium bovis protect bison against experimental bovine tuberculosis
title_short Orally administered live BCG and heat-inactivated Mycobacterium bovis protect bison against experimental bovine tuberculosis
title_sort orally administered live bcg and heat inactivated mycobacterium bovis protect bison against experimental bovine tuberculosis
topic Bison
Bovine TB
Heat Inactivated Vaccine
Live BCG
DIVA
url https://doi.org/10.1038/s41598-025-88176-0
work_keys_str_mv AT nirajanniroula orallyadministeredlivebcgandheatinactivatedmycobacteriumbovisprotectbisonagainstexperimentalbovinetuberculosis
AT priyaghodasara orallyadministeredlivebcgandheatinactivatedmycobacteriumbovisprotectbisonagainstexperimentalbovinetuberculosis
AT nelsonmarreros orallyadministeredlivebcgandheatinactivatedmycobacteriumbovisprotectbisonagainstexperimentalbovinetuberculosis
AT baileyfuller orallyadministeredlivebcgandheatinactivatedmycobacteriumbovisprotectbisonagainstexperimentalbovinetuberculosis
AT haleysanderson orallyadministeredlivebcgandheatinactivatedmycobacteriumbovisprotectbisonagainstexperimentalbovinetuberculosis
AT slimzriba orallyadministeredlivebcgandheatinactivatedmycobacteriumbovisprotectbisonagainstexperimentalbovinetuberculosis
AT stewwalker orallyadministeredlivebcgandheatinactivatedmycobacteriumbovisprotectbisonagainstexperimentalbovinetuberculosis
AT toddkshury orallyadministeredlivebcgandheatinactivatedmycobacteriumbovisprotectbisonagainstexperimentalbovinetuberculosis
AT jeffreymchen orallyadministeredlivebcgandheatinactivatedmycobacteriumbovisprotectbisonagainstexperimentalbovinetuberculosis